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OBJECTIVES: The objective of this literature review is to reiterate the epidemiology,
clinical signs, and radiological signs that should be consistent with a uterine sarcoma
as well as the precautionary pre- and postoperative principles that help prevent
morcellation of uterine sarcomas when treating patients with uterine fibroids.
METHOD: We conducted this literature review by consulting the Pubmed, Medline,
and Cochrane Systematic Review databases up to 28/02/2017 using the following
keywords: fibroid, myoma, leiomyoma, sarcoma, leiosarcoma, uterine cancer,
myomectomy, hysterectomy, morcellation, and uterine morcellation. We also used the
reference lists of the selected articles to find more data on the websites of North-
American and European learned societies that specialise in obstetrics and
gynaecology.
RESULTS: In the case of morcellation of uterine fibroids, the risk of an undiagnosed
uterine sarcoma is estimated to be between 1 in 278 to 1 in 1960 women.
Preoperative examination, free informed consent following discussion about the risks
and complications associated with morcellation, as well as research on the
contraindications to the use of morcellation are the crucial points addressed by
learned societies. The main solution recommended at present is morcellation confined
to a laparoscopic bag.
CONCLUSION: There is a risk of morcellating an occult sarcoma when performing a
myomectomyor hysterectomy for fibroids. Implementing the use of morcellation
containment bags should be the norm. The use of minimally invasive surgery
(laparoscopic orvaginal) and the associated benefit-risk ratio compared to a
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